AD Pharmaceuticals Co., Ltd. (Guangzhou)   Report issue

For profit Phase 2
Founded: Pratap Nagar India (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2018
NCT04169386
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AD Pharmaceuticals Co., Ltd. (Guangzhou) | AD Pharma (Guangdong)

Active Ingredients

Drugs in Phase 2 Trials (2)

ak102 (4 trials)

ezetimibe (zetia) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 2)

Hyperlipoproteinemia Type II (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2